文献速递其他结缔组织病

干燥综合征中IL-27对CD4+ T细胞功能调控受损影响异位淋巴结构形成

Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome.
PubMed 文献 · Arthritis Rheumatol · 2020-07-21

该研究通过小鼠唾液腺炎模型和干燥综合征(SS)患者样本,探讨白细胞介素-27(IL-27)在异位淋巴结构(ELS)形成中的作用。结果显示Il27ra-/-小鼠ELS更大更活跃、自身免疫增强且Th17反应扩增,IL-17阻断可抑制异常ELS反应;SS患者循环IL-27升高,且其T细胞中IL-27介导的IL-17分泌抑制严重受损并伴异常干扰素-γ释放。

要点

  • IL-27信号缺失导致小鼠唾液腺ELS增大、Th17反应扩增和自身免疫加重。
  • SS患者循环IL-27升高,腺体中DC-LAMP+树突状细胞表达IL-27并与T细胞关联。
  • SS患者T细胞中IL-27抑制IL-17分泌的功能严重受损,伴异常IFN-γ释放。

核心结论

  • IL-27通过控制Th17扩增限制ELS magnitude和功能的生理能力在SS患者中严重受损,提示该病存在免疫调节检查点缺陷。

研究设计与样本

  • 研究采用野生型和Il27ra-/-小鼠通过唾液腺插管复制缺陷腺病毒诱导ELS形成,并在有或无IL-17A中和条件下观察。
  • 在SS患者唾液腺活检样本中通过多色免疫荧光显微镜鉴定IL-27产生细胞,并通过基因表达和ELISA测定病灶和循环IL-27水平。
  • 使用荧光激活细胞分选和细胞因子释放实验评估IL-27对T细胞的体外效应。

主要发现

  • 在实验性唾液腺炎中,与野生型小鼠相比,Il27ra-/-小鼠具有更大和更活跃的ELS(焦点评分;P < 0.001)、自身免疫增强和Th17反应扩增(P < 0.001)。
  • 在Il27ra-/-小鼠中阻断IL-17可抑制异常ELS反应(B细胞和T细胞减少相对于对照;P < 0.01)。
  • SS患者循环IL-27水平升高(P < 0.01),且在唾液腺活检样本中IL-27由DC-LAMP+树突状细胞表达并与CD3+ T细胞相关。
  • 在SS患者T细胞(而非类风湿关节炎患者或健康对照的T细胞)中,IL-27介导的IL-17分泌抑制严重受损,并与IL-27刺激后异常干扰素-γ释放相关。

临床怎么用

  • SS患者中IL-27免疫调节检查点缺陷提示Th17通路和IL-27信号可能作为潜在干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Ectopic lymphoid structures (ELS) develop at sites of infection, autoimmunity, and cancer. In patients with Sjögren's syndrome (SS), ELS support autoreactive B cell activation and lymphomagenesis. Interleukin-27 (IL-27) is a key regulator of adaptive immunity and limits Th17 cell-driven pathology. We undertook this study to elucidate the role of IL-27 in ELS formation and function in autoimmunity using a murine model of sialadenitis and in patients with SS. METHODS: ELS formation was induced in wild-type and Il27ra-/- mice via salivary gland (SG) cannulation of a replication-deficient adenovirus in the presence or absence of IL-17A neutralization. In SG biopsy samples, IL-27-producing cells were identified by multicolor immunofluorescence microscopy. Lesional and circulating IL-27 levels were determined by gene expression and enzyme-linked immunosorbent assay. The in vitro effect of IL-27 on T cells was assessed using fluorescence-activated cell sorting and cytokine release. RESULTS: In experimental sialadenitis, Il27ra-/- mice had larger and more hyperactive ELS (focus score; P < 0.001), increased autoimmunity, and an expanded Th17 response (P < 0.001), compared to wild-type mice. IL-17 blockade in Il27ra-/- mice suppressed the aberrant ELS response (B and T cell reduction against control; P < 0.01). SS patients displayed increased circulating IL-27 levels (P < 0.01), and in SG biopsy samples, IL-27 was expressed by DC-LAMP+ dendritic cells in association with CD3+ T cells. Remarkably, in SS T cells (but not in T cells from patients with rheumatoid arthritis or healthy controls), IL-27-mediated suppression of IL-17 secretion was severely impaired and associated with an aberrant interferon-γ release upon IL-27 stimulation. CONCLUSION: Our data indicate that the physiologic ability of IL-27 to limit the magnitude and function of ELS through control of Th17 cell expansion is severely impaired in SS patients, highlighting a defective immunoregulatory checkpoint in this condition.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Lucchesi D, Coleby R, Pontarini E, et al. Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome. Arthritis Rheumatol. 2020. PMID: 32307922. doi:10.1002/art.41289

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。